cerrar
Tagged with turkey

Interview: Tugce Gozacan, Owner & Okan Gozacan, Chairman,…
Tugce Gozacan (pictured) and Okan Gozacan, Owner and Chairman of Marmara Ecza respectively, discuss what qualities are crucial for suppliers in the…

Interview: Ersan Kuçuk – General Manager, Drogsan, Turkey
The general manager of Drogsan, Ersan Kuçuk elaborates on the company’s efforts in shifting towards more value-added pharmaceutical products,…

Interview: Arafat Yadigar
 – General Manager
,…
Consumer healthcare products manufacturer Winalite is working to penetrate the Turkish market, but with regulations complicating bringing their…

Interview: Ozgur Tomruk – Managing Director, Global…
Ozgur Tomruk, J&J’s Managing Director for Global Surgery talks about Turkey’s importance for the company, the priorities they have set,…

Interview: Nil Tunaşar – Managing Partner, Transorient,…
Nil Tunaşar, managing partner of Transorient, discusses significance of tracking performance metrics among 3PL providers, the organization’s…

Interview: Matthias Diewald (MD)
 – General Manager and…
Matthias Diewald (MD) and Asli Volkan (AV) elaborate on HELM Kimya’s longstanding presence within Turkey and the type of market opportunities…

Interview: Muzaffer Bal – 
General Manager, Ali Raif…
The general manager of Ali Raif, Muzaffer Bal illustrates the various success factors that allowed the company to secure market leading positions…

Interview: Prof. Haluk Ataoğlu, MD PhD – CEO Matriks…
Haluk Ataoglu, academic turned founder of Matriks Biotek®, talks about his aspirations for his company and the Turkish R&D landscape as well as…

Interview: Prof. Dr. Murat Özgören – Vice-Rector, Dokuz…
Prof. Dr. Murat Özgören, the architect behind the ambitious BioIzmir project, talks about its potential and how it intends to educate new talent to…

Interview: Ahu Yazici – General Manager, BMS, Turkey
BMS Turkey’s new general manager discusses Opdivo (nivolumab) their revolutionary new product for squamous non-small cell lung cancer,…

Turkey Will Increase Its Investment In Pharma R&D
Multinational R&D investment in Turkey, particularly investment in clinical trials, has been quite limited relative to the size of the Turkish…

How Turkey made its Pharma Sector More Efficient
Over the past six years, Turkey has consistently lowered its drugs prices and guided its companies to greater efficiency. “Reference prices in…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here